Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duration of Humoral Immunological Memory to a Single Dose of rVSV∆G-ZEBOV-GP
NCT06100913Phase 2Active, not recruiting
- Sponsor
- Emory University
- Start
- Aug 2024
- Primary completion
- Aug 2027
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Ebola Zaire vaccine (live, attenuated) in Ebola virus disease (EVD), sponsored by Emory University. Started Aug 2024; status: active, not recruiting.
02
Drugs
Ebola Zaire vaccine (live, attenuated)
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT06100913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06100913.